Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 340

2.

Innovations in Statistical Review at European Urology.

Assel M, Sjoberg DD, Catto JWF, Vickers AJ.

Eur Urol. 2018 Oct 13. pii: S0302-2838(18)30736-X. doi: 10.1016/j.eururo.2018.09.046. [Epub ahead of print]

PMID:
30327270
3.

Clinical Utility of Prostate and Tumor Volume-Related Parameters Following Radical Prostatectomy for Localized Prostate Cancer.

Ito Y, Udo K, Vertosick EA, Sjoberg DD, Vickers AJ, Al-Ahmadie HA, Chen YB, Gopalan A, Sirintrapun SJ, Tickoo SK, Scardino PT, Eastham JA, Reuter VE, Fine SW.

J Urol. 2018 Oct 6. pii: S0022-5347(18)43967-5. doi: 10.1016/j.juro.2018.09.060. [Epub ahead of print]

PMID:
30300632
4.

Redesigning Prostate Cancer Screening Strategies to Reduce Overdiagnosis.

Vickers AJ.

Clin Chem. 2018 Oct 1. pii: clinchem.2018.287094. doi: 10.1373/clinchem.2018.287094. [Epub ahead of print] No abstract available.

PMID:
30274977
5.

Comparison of Post-Radical Cystectomy Ileus Rates Using GIA-80 versus GIA-60 Intestinal Stapler Device.

Ghanaat M, Winer AG, Sjoberg DD, Poon BY, Kashan M, Tin AL, Sfakianos JP, Cha EK, Donahue TF, Dalbagni G, Herr HW, Bochner BH, Vickers AJ, Donat SM.

Urology. 2018 Sep 20. pii: S0090-4295(18)30967-1. doi: 10.1016/j.urology.2018.09.010. [Epub ahead of print]

PMID:
30244117
6.

Challenges in Adopting Level 1 Evidence for Multiparametric Magnetic Resonance Imaging as a Biomarker for Prostate Cancer Screening.

Kim SJ, Vickers AJ, Hu JC.

JAMA Oncol. 2018 Sep 13. doi: 10.1001/jamaoncol.2018.4160. [Epub ahead of print] No abstract available.

PMID:
30242308
7.

Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators.

Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, Roobol MJ, Steyerberg EW.

Eur Urol. 2018 Sep 19. pii: S0302-2838(18)30640-7. doi: 10.1016/j.eururo.2018.08.038. [Epub ahead of print] Review.

PMID:
30241973
8.

Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.

Preston MA, Gerke T, Carlsson SV, Signorello L, Sjoberg DD, Markt SC, Kibel AS, Trinh QD, Steinwandel M, Blot W, Vickers AJ, Lilja H, Mucci LA, Wilson KM.

Eur Urol. 2018 Sep 17. pii: S0302-2838(18)30627-4. doi: 10.1016/j.eururo.2018.08.032. [Epub ahead of print]

PMID:
30237027
9.

Are We Improving Erectile Function Recovery After Radical Prostatectomy? Analysis of Patients Treated over the Last Decade.

Capogrosso P, Vertosick EA, Benfante NE, Eastham JA, Scardino PJ, Vickers AJ, Mulhall JP.

Eur Urol. 2018 Sep 17. pii: S0302-2838(18)30641-9. doi: 10.1016/j.eururo.2018.08.039. [Epub ahead of print]

PMID:
30237021
10.

Temporal Trend in Incidental Prostate Cancer Detection at Surgery for Benign Prostatic Hyperplasia.

Capogrosso P, Capitanio U, Vertosick EA, Ventimiglia E, Chierigo F, Oreggia D, Moretti D, Briganti A, Vickers AJ, Montorsi F, Salonia A.

Urology. 2018 Aug 20. pii: S0090-4295(18)30783-0. doi: 10.1016/j.urology.2018.07.028. [Epub ahead of print]

PMID:
30138683
11.

Clinical utility of total length Gleason pattern 4 on biopsy in men with Grade Group 2 prostate cancer.

Dean LW, Assel M, Sjoberg DD, Vickers AJ, Al-Ahmadie HA, Chen YB, Gopalan A, Sirintrapun SJ, Tickoo SK, Eastham JA, Scardino PT, Reuter VE, Ehdaie B, Fine SW.

J Urol. 2018 Aug 1. pii: S0022-5347(18)43632-4. doi: 10.1016/j.juro.2018.07.062. [Epub ahead of print]

PMID:
30076908
12.

A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.

Bao T, Seidman AD, Piulson L, Vertosick E, Chen X, Vickers AJ, Blinder VS, Zhi WI, Li Q, Vahdat LT, Dickler MN, Robson ME, Mao JJ.

Eur J Cancer. 2018 Sep;101:12-19. doi: 10.1016/j.ejca.2018.06.008. Epub 2018 Jul 13.

PMID:
30007894
13.

Prognosis, Effect Modification, and Mediation.

Vickers AJ, Steineck G.

Eur Urol. 2018 Sep;74(3):243-245. doi: 10.1016/j.eururo.2018.05.027. Epub 2018 Jun 13. No abstract available.

PMID:
29908877
14.

Value of a Statistical Model Based on Four Kallikrein Markers in Blood, Commercially Available as 4Kscore, in All Reasonable Prostate Biopsy Subgroups.

Vickers AJ, Vertosick EA, Sjoberg DD.

Eur Urol. 2018 Oct;74(4):535-536. doi: 10.1016/j.eururo.2018.05.032. Epub 2018 Jun 11. No abstract available.

PMID:
29903434
15.

Pharmacogenomics of antioxidant supplementation to prevent age-related macular degeneration.

Vickers AJ.

Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):E5639. doi: 10.1073/pnas.1803536115. Epub 2018 Jun 7. No abstract available.

PMID:
29880714
16.

Effects of pathological upstaging or upgrading on metastasis and cancer-specific mortality in men with clinical low-risk prostate cancer.

Kovac E, Vertosick EA, Sjoberg DD, Vickers AJ, Stephenson AJ.

BJU Int. 2018 May 26. doi: 10.1111/bju.14418. [Epub ahead of print]

PMID:
29802773
17.

A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts.

Ankerst DP, Straubinger J, Selig K, Guerrios L, De Hoedt A, Hernandez J, Liss MA, Leach RJ, Freedland SJ, Kattan MW, Nam R, Haese A, Montorsi F, Boorjian SA, Cooperberg MR, Poyet C, Vertosick E, Vickers AJ.

Eur Urol. 2018 Aug;74(2):197-203. doi: 10.1016/j.eururo.2018.05.003. Epub 2018 May 16.

PMID:
29778349
18.

Reply.

Vickers AJ.

Ophthalmology. 2018 May;125(5):e35. doi: 10.1016/j.ophtha.2017.12.017. No abstract available.

PMID:
29681305
19.

Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men.

Sjoberg DD, Vickers AJ, Assel M, Dahlin A, Poon BY, Ulmert D, Lilja H.

Eur Urol. 2018 Jun;73(6):941-948. doi: 10.1016/j.eururo.2018.02.016. Epub 2018 Mar 5.

PMID:
29519548
20.

Statistical Code for Clinical Research Papers in a High-Impact Specialist Medical Journal.

Assel M, Vickers AJ.

Ann Intern Med. 2018 Jun 5;168(11):832-833. doi: 10.7326/M17-2863. Epub 2018 Feb 6. No abstract available.

PMID:
29404569
21.

Risk Based Surveillance after Surgical Treatment of Renal Cell Carcinoma.

Capogrosso P, Larcher A, Sjoberg DD, Vertosick EA, Cianflone F, Dell'Oglio P, Carenzi C, Salonia A, Vickers AJ, Montorsi F, Bertini R, Capitanio U.

J Urol. 2018 Jul;200(1):61-67. doi: 10.1016/j.juro.2018.01.072. Epub 2018 Jan 31.

PMID:
29371091
22.

Just-in-time consent: The ethical case for an alternative to traditional informed consent in randomized trials comparing an experimental intervention with usual care.

Vickers AJ, Young-Afat DA, Ehdaie B, Kim SY.

Clin Trials. 2018 Feb;15(1):3-8. doi: 10.1177/1740774517746610. Epub 2017 Dec 11.

PMID:
29224379
23.

Acupuncture for Chronic Pain: Update of an Individual Patient Data Meta-Analysis.

Vickers AJ, Vertosick EA, Lewith G, MacPherson H, Foster NE, Sherman KJ, Irnich D, Witt CM, Linde K; Acupuncture Trialists' Collaboration.

J Pain. 2018 May;19(5):455-474. doi: 10.1016/j.jpain.2017.11.005. Epub 2017 Dec 2. Review.

PMID:
29198932
24.

The National Cancer Institute's Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research Gaps.

Zia FZ, Olaku O, Bao T, Berger A, Deng G, Fan AY, Garcia MK, Herman PM, Kaptchuk TJ, Ladas EJ, Langevin HM, Lao L, Lu W, Napadow V, Niemtzow RC, Vickers AJ, Shelley Wang X, Witt CM, Mao JJ.

J Natl Cancer Inst Monogr. 2017 Nov 1;2017(52). doi: 10.1093/jncimonographs/lgx005.

PMID:
29140486
25.

Reply.

MacPherson H, Vertosick EA, Vickers AJ.

Pain. 2017 Dec;158(12):2499-2500. doi: 10.1097/j.pain.0000000000001077. No abstract available.

PMID:
29120952
26.

Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening.

Assel M, Dahlin A, Ulmert D, Bergh A, Stattin P, Lilja H, Vickers AJ.

Eur Urol. 2018 Jun;73(6):961-967. doi: 10.1016/j.eururo.2017.10.004. Epub 2017 Oct 21.

PMID:
29066048
27.

Use of Digital Rectal Examination as an Adjunct to Prostate Specific Antigen in the Detection of Clinically Significant Prostate Cancer.

Halpern JA, Oromendia C, Shoag JE, Mittal S, Cosiano MF, Ballman KV, Vickers AJ, Hu JC.

J Urol. 2018 Apr;199(4):947-953. doi: 10.1016/j.juro.2017.10.021. Epub 2017 Oct 20.

PMID:
29061540
28.

A systematic review of instrumental variable analyses using geographic region as an instrument.

Vertosick EA, Assel M, Vickers AJ.

Cancer Epidemiol. 2017 Dec;51:49-55. doi: 10.1016/j.canep.2017.10.005. Epub 2017 Oct 14. Review.

PMID:
29035744
29.

Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration: Independent Statistical Evaluations of Data from the Age-Related Eye Disease Study.

Assel MJ, Li F, Wang Y, Allen AS, Baggerly KA, Vickers AJ.

Ophthalmology. 2018 Mar;125(3):391-397. doi: 10.1016/j.ophtha.2017.09.008. Epub 2017 Oct 9.

PMID:
29032853
30.

Concordance between patient-reported and physician-reported sexual function after radical prostatectomy.

Thong AE, Ying Poon B, Lee JK, Vertosick E, Sjoberg DD, Vickers AJ, Ehdaie B.

Urol Oncol. 2018 Feb;36(2):80.e1-80.e6. doi: 10.1016/j.urolonc.2017.09.017. Epub 2017 Oct 12.

PMID:
29031420
31.

Biopsy Core Features are Poor Predictors of Adverse Pathology in Men with Grade Group 1 Prostate Cancer.

Audenet F, Vertosick EA, Fine SW, Sjoberg DD, Vickers AJ, Reuter VE, Eastham JA, Scardino PT, Touijer KA.

J Urol. 2018 Apr;199(4):961-968. doi: 10.1016/j.juro.2017.10.010. Epub 2017 Oct 10.

PMID:
29030317
32.

Preexisting Cardiovascular Risk and Subsequent Heart Failure Among Non-Hodgkin Lymphoma Survivors.

Salz T, Zabor EC, de Nully Brown P, Dalton SO, Raghunathan NJ, Matasar MJ, Steingart R, Vickers AJ, Svenssen Munksgaard P, Oeffinger KC, Johansen C.

J Clin Oncol. 2017 Dec 1;35(34):3837-3843. doi: 10.1200/JCO.2017.72.4211. Epub 2017 Sep 18.

PMID:
28922087
33.

Prostate Cancer Screening: Time to Question How to Optimize the Ratio of Benefits and Harms.

Vickers AJ.

Ann Intern Med. 2017 Oct 3;167(7):509-510. doi: 10.7326/M17-2012. Epub 2017 Sep 5. No abstract available.

PMID:
28869975
34.

Incidence and Effect of Thromboembolic Events in Radical Cystectomy Patients Undergoing Preoperative Chemotherapy for Muscle-invasive Bladder Cancer.

Bagrodia A, Sukhu R, Winer AG, Levy E, Vacchio M, Lee B, Pietzak EJ, Donahue TF, Cha E, Iyer G, Sjoberg DD, Vickers AJ, Rosenberg JE, Bajorin DF, Dalbagni G, Bochner BH.

Clin Genitourin Cancer. 2017 Aug 10. pii: S1558-7673(17)30232-X. doi: 10.1016/j.clgc.2017.07.022. [Epub ahead of print]

PMID:
28866245
35.

Improved Recovery of Erectile Function in Younger Men after Radical Prostatectomy: Does it Justify Immediate Surgery in Low-risk Patients?

Lee JK, Sjoberg DD, Miller MI, Vickers AJ, Mulhall JP, Ehdaie B.

Eur Urol. 2018 Jan;73(1):33-37. doi: 10.1016/j.eururo.2017.08.007. Epub 2017 Aug 26.

PMID:
28851580
36.

Erratum to: Manifesto: towards a clinically-oriented psychometrics.

Vickers AJ, Chen LY.

Health Qual Life Outcomes. 2017 May 22;15(1):112. doi: 10.1186/s12955-017-0684-y. No abstract available.

37.

Manifesto: towards a clinically-oriented psychometrics.

Vickers AJ, Chen LY.

Health Qual Life Outcomes. 2017 Apr 26;15(1):83. doi: 10.1186/s12955-017-0655-3. Erratum in: Health Qual Life Outcomes. 2017 May 22;15(1):112.

38.

Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments.

Vertosick EA, Vickers AJ, Cowan JE, Broering JM, Carroll PR, Cooperberg MR.

J Urol. 2017 Sep;198(3):671-677. doi: 10.1016/j.juro.2017.03.121. Epub 2017 Mar 22.

39.

Response to "Comment on: Decisional Conflict, Regret, and the Burden of Rational Decision Making".

Vickers AJ.

Med Decis Making. 2017 May;37(4):E362. doi: 10.1177/0272989X17691760. Epub 2017 Feb 15. No abstract available.

40.

Impact of self-reported data on the acquisition of multi-generational family history and lifestyle factors among women seen in a high-risk breast screening program: a focus on modifiable risk factors and genetic referral.

Rosenberger LH, Weber R, Sjoberg D, Vickers AJ, Mangino DA, Morrow M, Pilewskie ML.

Breast Cancer Res Treat. 2017 Apr;162(2):275-282. doi: 10.1007/s10549-017-4115-x. Epub 2017 Jan 28.

41.

Decision Curves, Calibration, and Subgroups.

Vickers AJ, Van Calster B, Steyerberg E.

J Clin Oncol. 2017 Feb;35(4):472-473. doi: 10.1200/JCO.2016.69.1576. Epub 2016 Nov 14. No abstract available.

PMID:
28129527
42.

A head and neck cancer intervention for use in survivorship clinics: a protocol for a feasibility study.

Salz T, McCabe MS, Oeffinger KC, Corcoran S, Vickers AJ, Salner AL, Dornelas E, Schnall R, Raghunathan NJ, Fortier E, Baxi SS.

Pilot Feasibility Stud. 2016 May 5;2:23. eCollection 2016.

43.

Decisional Conflict, Regret, and the Burden of Rational Decision Making.

Vickers AJ.

Med Decis Making. 2017 Jan;37(1):3-5. No abstract available.

44.

Implementation of Dynamically Updated Prediction Models at the Point of Care at a Major Cancer Center: Making Nomograms More Like Netflix.

Vickers AJ, Kent M, Scardino PT.

Urology. 2017 Apr;102:1-3. doi: 10.1016/j.urology.2016.10.049. Epub 2016 Nov 24. No abstract available.

45.

Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel.

Kim EH, Andriole GL, Crawford ED, Sjoberg DD, Assel M, Vickers AJ, Lilja H.

J Urol. 2017 Apr;197(4):1041-1047. doi: 10.1016/j.juro.2016.10.089. Epub 2016 Nov 1.

46.

The persistence of the effects of acupuncture after a course of treatment: a meta-analysis of patients with chronic pain.

MacPherson H, Vertosick EA, Foster NE, Lewith G, Linde K, Sherman KJ, Witt CM, Vickers AJ.

Pain. 2017 May;158(5):784-793. doi: 10.1097/j.pain.0000000000000747. Review.

47.

Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis.

Carlsson SV, de Carvalho TM, Roobol MJ, Hugosson J, Auvinen A, Kwiatkowski M, Villers A, Zappa M, Nelen V, Páez A, Eastham JA, Lilja H, de Koning HJ, Vickers AJ, Heijnsdijk EA.

Cancer. 2016 Nov 15;122(21):3386-3393. doi: 10.1002/cncr.30192. Epub 2016 Jul 26.

48.

External Evaluation of a Novel Prostate Cancer Risk Calculator (ProstateCheck) Based on Data from the Swiss Arm of the ERSPC.

Poyet C, Wettstein MS, Lundon DJ, Bhindi B, Kulkarni GS, Saba K, Sulser T, Vickers AJ, Hermanns T.

J Urol. 2016 Nov;196(5):1402-1407. doi: 10.1016/j.juro.2016.05.081. Epub 2016 May 14.

49.

Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts.

Chen R, Sjoberg DD, Huang Y, Xie L, Zhou L, He D, Vickers AJ, Sun Y; Chinese Prostate Cancer Consortium; Prostate Biopsy Collaborative Group.

J Urol. 2017 Jan;197(1):90-96. doi: 10.1016/j.juro.2016.08.103. Epub 2016 Sep 2.

50.

Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain.

Saramago P, Woods B, Weatherly H, Manca A, Sculpher M, Khan K, Vickers AJ, MacPherson H.

BMC Med Res Methodol. 2016 Oct 6;16(1):131.

Supplemental Content

Loading ...
Support Center